Shopping Cart
- Remove All
- Your shopping cart is currently empty
Icotrokinra (JNJ-77242113) is an orally effective selective antagonist of the IL-23 receptor (IL-23 receptor), demonstrating high affinity with a dissociation constant (Kd) of 7.1 pM for the human IL-23 receptor (hIL-23R). It inhibits IL-23-induced STAT3 phosphorylation in PBMC with an IC50 of 5.6 pM and suppresses the production of IFNγ and IL-17A at the epidermal level induced by IL-23. Additionally, Icotrokinra exhibits anti-inflammatory activity in a rat model of TNBS-induced colitis.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | Backorder | |
50 mg | Inquiry | Backorder |
Description | Icotrokinra (JNJ-77242113) is an orally effective selective antagonist of the IL-23 receptor (IL-23 receptor), demonstrating high affinity with a dissociation constant (Kd) of 7.1 pM for the human IL-23 receptor (hIL-23R). It inhibits IL-23-induced STAT3 phosphorylation in PBMC with an IC50 of 5.6 pM and suppresses the production of IFNγ and IL-17A at the epidermal level induced by IL-23. Additionally, Icotrokinra exhibits anti-inflammatory activity in a rat model of TNBS-induced colitis. |
Targets&IC50 | IL-23:7.1 pM (Kd) |
Alias | PN-235, JNJ-77242113, JNJ-2113 |
Molecular Weight | 1898.17 |
Formula | C90H120N20O22S2 |
Cas No. | 2763602-16-8 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.